UK's NICE Clears Roche Drug For Use In Follicular Lymphoma Capital.gr (press release) The decision confirms draft guidance issued last May and follows months of consideration by the National Institute for Health and Clinical Excellence, which has now approved use of MabThera, also known as rituximab, for first-line maintenance treatment ... |
